Notable Stocks in Focus: Pacific Biosciences of California, Inc. (NASDAQ:PACB) and Novavax, Inc. (NASDAQ:NVAX)

Recent session action on shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) puts the stock on today’s active list. Since the open, shares have moved 13.99% after recently hitting the $4.61 mark.

Digging a bit further, company shares have been noted -51.53% off the 52 week high and 49.51% away from the 52 week low. Looking at a shorter time period, shares have been seen 13.70% away from the 50 day high and 49.51% off the 50 day low price.

Analyst Roundup

Covering sell-side analysts have recently weighed in on shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB). At the time of writing, the First Call consensus price target for the company is $5.95. The current consensus recommendation provided by covering analysts is 1.80. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.

Prior Stock Performance Recap

Since the beginning of the calendar year, the stock is 5.53%. For the quarter, shares have been noted at 1.78%. Share performance for the month is currently at 15.23%. Tightening the gaze, stock performance for the last 5 trading days is 24.15%.

Session activity on Novavax, Inc.(NASDAQ:NVAX) shares bumps the stock on today’s most active list. After a recent spot-check, the stock has touched $0.98 which represents a change from the open of -4.41%. Company shares have been seen trading -88.52% off of the 52 week high and 33.56% away from the 52 week low. Narrowing in, the stock is at a distance of -44.29% from the 50 day high and 8.00% off of the 50 day low.Covering sell-side analysts have recently weighed in on shares of Novavax, Inc. (NASDAQ:NVAX). At the time of writing, the First Call consensus price target for the company is $1.78. The current consensus recommendation provided by covering analysts is 2.90.

Since the beginning of the calendar year, the stock is -19.84%. For the quarter, shares have been noted at 35.86%. Share performance for the month is currently at -14.41%.

Tightening the gaze, stock performance for the last 5 trading days is 5.25%.

Leave a Comment